Share this:
Email this page Share this on LinkedIn Share this on Twitter Share with your XING network

Biotech Company Presentation Application

Biotechnology companies interested in partnering their technologies or products, initiating strategic alliances, or tapping into the international financing network are welcome to apply to present at BioPharm America™ 2012.

A panel of industry experts will select the presenting companies. The panel will make each decision based on the company profile that was submitted (deadline: May 31, 2012) and on the interests of pharmaceutical companies, consistency with BioPharm America's focus and the licensability of products or technology.

Presentation guidelines

Presentations are 14 minutes long and should focus on the following points:
  • Brief corporate background
  • Key products or technologies
  • Existing alliances
  • Type of alliances sought

Fee structure

BioPharm America 2012USDComment
Company presentation fee
(in addition to the applicable registration fee below)
1,100 by May 31, 2012
Company registration fee1,795 
Minimum presentation fee per company
(Presentation + Registration)
2,895 
  • To guarantee the early registration discount payments must be received by July 31, 2012.
  • Additional attendees from the same company will be invoiced for the registration fee.
  • Companies with three full-paying delegates will receive one complimentary ticket for the fourth attendee from their company.

Your registration fee covers

  • Submission of up to 150 requests per company for one-to-one meetings during the conference
  • Access to all workshops, presentations, panel discussions and the exhibition hall
  • Publication of your company and personal profiles on partneringONE®, BioPharm America 2012's partnering system
  • Breakfast, lunch, afternoon snacks, complimentary coffee and other non-alcoholic beverages in the conference center
  • Three evening networking receptions
Now accepting applications to present

Application form

Presentation Information

Now accepting applications

Biotech Company Presentation Application ►

Deadline to submit an application
to present is May 31, 2012

Companies will be notified about the status/outcome of their application by end of June, 2012.

For more information, please contact:

Christina Kirsch
EBD Group
+1 760 930 0500
ckirsch@ebdgroup.com

Payment/Invoice

Companies selected for a presentation will receive an invoice shortly after they have been notified about their assigned presentation slot.

Company profile

Your company profile will be published in the password-protected partnering section of the BioPharm America website.

Company profiles will be available as a download. You can access the download tool within the partneringONE® system starting September 15, 2012 and it will remain available for a year. Please note that profiles received after September 11, 2012 will not be included in the download.

Sending a replacement

Please register the new person who will attend the conference in your place at www.ebdgroup.com/bpa/registration/index.php and note "replaces (your name) who will no longer attend" in the comment field within the online registration form.

We will then activate the new registration, deactivate your registration and transfer your meeting requests and scheduled meetings.

Please do NOT update your personal profile page with the name and contact data of the new attendee.

Please contact Holly Mersy at hmersy@ebdgroup.com for further questions.

Cancellation policy

Cancellations must be sent by July 31, 2012, to Holly Mersy at hmersy@ebdgroup.com to receive a refund (minus a USD 300 processing fee) or the full registration and presenting fee will be charged. Refunds will be processed after BioPharm America 2012.

After July 31, 2012, the full registration fee is applicable. However, a paid registration is transferable to a replacement from your company.

Please note that no-shows will be billed for the full registration fee and, if applicable, the full presentation fee.

Arrow Up


© 2009–2012 EBD Group, Inc.
EBD GroupMassachusetts Biotechnology Council